FLOW CYTOMETRY The Flow Cytometry Core has been in continuous operation under the direction of Dr. Robert Todd since October 1984. The Core (as part of the University of Michigan Medical School's Biomedical Research Core Facilities) provides flow cytometry instrumentation and expertise to the life sciences community of the University of Michigan including the University of Michigan Comprehensive Cancer Center. During calendar year 2004, 143 individual investigators made use of the Core of which 97 where Cancer Center members (68%);Cancer Center members accounted for approximately 81% of total facility usage (3,726 out of 4,571 facility hours). In year one of the proposed budget, the Cancer Center support grant will provide $200,543 representing 39% of a total operating budget of $512,033. In return for this support, Cancer Center members are eligible for a 50% discounted recharge rate. Individual investigators deliver pre-processed samples to the Core for flow cytometric analysis or cell sorting as conducted by five Core staff utilizing four high-speed cell sorters and two fluorescence analyzers. The hours of Core operation is from 9am to 9pm Monday thru Friday (operator conducted analysis on high speed sorters) with unlimited hours of operation (by client staff) on the analyser instruments. Among the broad range of applications available to Flow Cytometry Core users are the following: single/multicolor immunofluorescence;DNA content/cell cycle estimates;vital DNA content;RNA/total protein measurements;chromosome analysis/sorting;proliferation indicators;kinetic measurements;metabolic functions;apoptosis detection; cell tracking;drug resistance phenotype detection;lipid-ligand interaction;cell sorting.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046592-22
Application #
7917267
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-06-01
Budget End
2010-05-31
Support Year
22
Fiscal Year
2009
Total Cost
$230,622
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Maust, Joel D; Frankowski-McGregor, Christy L; Bankhead 3rd, Armand et al. (2018) Cyclooxygenase-2 Influences Response to Cotargeting of MEK and CDK4/6 in a Subpopulation of Pancreatic Cancers. Mol Cancer Ther 17:2495-2506
Hoban, Connor W; Beesley, Lauren J; Bellile, Emily L et al. (2018) Individualized outcome prognostication for patients with laryngeal cancer. Cancer 124:706-716
Valenciaga, Anisley; Saji, Motoyasu; Yu, Lianbo et al. (2018) Transcriptional targeting of oncogene addiction in medullary thyroid cancer. JCI Insight 3:
Arthur, Anna E; Goss, Amy M; Demark-Wahnefried, Wendy et al. (2018) Higher carbohydrate intake is associated with increased risk of all-cause and disease-specific mortality in head and neck cancer patients: results from a prospective cohort study. Int J Cancer 143:1105-1113
Anwar, Talha; Arellano-Garcia, Caroline; Ropa, James et al. (2018) p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis. Nat Commun 9:2801
Akkina, Sarah R; Kim, Roderick Y; Stucken, Chaz L et al. (2018) Is There a Difference in Staging and Treatment of Head and Neck Squamous Cell Tumors Between Tertiary Care and Community-Based Institutions? Laryngoscope Investig Otolaryngol 3:290-295
Hartlerode, Andrea J; Regal, Joshua A; Ferguson, David O (2018) Reversible mislocalization of a disease-associated MRE11 splice variant product. Sci Rep 8:10121
Giraldez, Maria D; Spengler, Ryan M; Etheridge, Alton et al. (2018) Comprehensive multi-center assessment of small RNA-seq methods for quantitative miRNA profiling. Nat Biotechnol 36:746-757
Haley, Henry R; Shen, Nathan; Qyli, Tonela et al. (2018) Enhanced Bone Metastases in Skeletally Immature Mice. Tomography 4:84-93
Fritsche, Lars G; Gruber, Stephen B; Wu, Zhenke et al. (2018) Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative. Am J Hum Genet 102:1048-1061

Showing the most recent 10 out of 1493 publications